Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease

Summary

Heart failure (HF) is an epidemic and is a major burden on the US healthcare system. The most common cardiovascular endpoint is HF. Thus, novel interventions to prevent HF in chronic kidney disease (CKD) are highly desirable. This study will assess: the variability in the response to isosorbide mononitrate (ISMN) therapy; the degree of change in central hemodynamics and cardiac endpoints through analysis of changes in left ventricle (LV) mass, diffuse myocardial fibrosis, and myocardial systolic and diastolic function.

Timeline

Start

2016-05

Primary completion

2019-03

Completion

2019-03

Outcome

Outcome not reported

Stopped (Business): “lack of funding”

Drugs

Indications